You are here

West Africa Disaster Preparedness Initiative (WADPI)

Primary tabs

This working group is focused on discussions about the West Africa Disaster Preparedness Initiative (WADPI).

The mission of this working group is to focus on discussions about the West Africa Disaster Preparedness Initiative (WADPI).

Members

Carrielaj davidmc Kathy Gilbeaux LadyCath mdmcdonald MDMcDonald_me_com
Obilia Kamara Paulshido

Email address for group

wadpi@m.resiliencesystem.org

West Africa’s War on Drugs

Tuesday May 3, 2016

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Global Fund commits more to health recovery

By Ade Campbell
Tuesday May 3, 2016

Meeting / Event Tags: 
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Sewa Farm to invest $30-40M in agriculture

Tuesday May 3, 2016

Meeting / Event Tags: 
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Gento Group appeal to road users

 

By: SEM Contributor on May 4, 2016.

 

The Director Gento Group, Mohamed Gento Kamara has appeal to road users for them to exercise patience with them as they want to do long lasting job.  (Photo: Jomo Kenyatta Road)

 

Gento Group Director was explaining why they failed to meet their deadline of completing the Jomo Kenyatta/King Harman Road junction by end of April.

 

Giving reasons for not meeting their deadline, Gento Group Director, Mohamed Gento Kamara told this Medium that just after they made the declaration to complete the tarring of that road by April ending, the government asked them to construct a foot bridge along New England Ville junction which he said stalled their timetable for two weeks as they need to draw the plan for that foot bridge and also start the construction.

 

Meeting / Event Tags: 
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Zika vaccine efficacy trials could start in 2017

By Jon CohenMay. 3, 2016 

In the most optimistic scenario, a Zika vaccine could prove its worth by the start of 2018, Anthony Fauci, head of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) in Bethesda, Maryland, said today.

Meeting / Event Tags: 
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Ebola vaccine: Promising phase I trials

Date:May 3, 2016Source:German Center for Infection ResearchSummary:The clinical phase I trial of a potential vaccine against the dreaded Ebola virus has been successfully completed at four partner sites in Africa and Europe. The safety of the tested vaccine 'rVSV-ZEBOV', which induces persistent antibodies against the virus, has been confirmed by researchers.

"The results for tolerability, safety, and the immune response to the vaccine candidate are very promising," explains Prof Marylyn Addo. The antibodies which developed against the virus were still detectable after six months. Addo is convinced, "With this, a single vaccine could provide lasting protection against Ebola." The infectious disease specialist, who works for the German Center for Infection Research at the University Medical Center Hamburg Eppendorf (UKE) in Hamburg, led the trial in Hamburg. A total of 158 healthy adult volunteers were tested in Hamburg, as well as at the partner sites in Geneva (Switzerland), Lambaréné; (Gabon) and Kilifi (Kenya).

Meeting / Event Tags: 
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

How Ebola Destroyed Maternal Health Gains in Sierra Leone

May. 2, 2016

When she went into labor last November, 18-year-old Kema James climbed onto the back of a motorbike taxi in her village in eastern Sierra Leone and rode half an hour to the main government hospital in the nearby city of Kenema.

When her baby was delivered, he was sickly yellow and stricken with sepsis, an ailment caused by bacteria in the blood, and he hung limply in the hands of the hospital staff. He died five days later before he could be named.

Meeting / Event Tags: 
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Researchers look to repurpose approved drugs to treat Zika virus

published by 

6:47 p.m. EDT May 2, 2016

ATLANTA — The need for drugs to prevent and treat Zika infections grows with every new patient diagnosed. The virus causes devastating birth defects and is strongly linked to a type of paralysis called Guillain-Barre syndrome.

There are currently no approved drugs against Zika; developing a new medication for any disease can take 10 to 20 years.

"The sense of urgency is enormous," said Mauro Martins Teixeira, who heads the immunopharmacology laboratory at the Federal University of Minas Gerais in Brazil. "In an emergency, everyone wants quick answers."

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks